Heidelberg, Germany

Harish Srinivasan

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Deutsches Krebsforschungszentrum, Institut Curie. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harish Srinivasan. Retrieved from https://idiyas.com/inventor/harish-srinivasan-4retb4d3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Harish Srinivasan: Innovator in Cancer Prediction

Introduction

Harish Srinivasan is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of cancer prediction, particularly in bladder cancer. With a total of 2 patents, his work focuses on innovative methods for predicting cancer recurrence.

Latest Patents

One of Harish Srinivasan's latest patents is titled "Prediction of recurrence for bladder cancer by a protein signature in tissue samples." This invention pertains to a method for predicting the risk of recurrence of bladder cancer in a subject after treatment. The method involves determining the amount of at least one biomarker and comparing it with a reference amount. This comparison allows for the prediction of the risk of recurrence. Additionally, the invention includes diagnostic devices and kits for implementing these methods.

Career Highlights

Throughout his career, Harish has worked with prestigious organizations such as Institut Curie and Deutsches Krebsforschungszentrum. His experience in these institutions has contributed to his expertise in cancer research and innovation.

Collaborations

Harish has collaborated with notable colleagues in his field, including François Radvanyi and Jörg Hoheisel. These collaborations have further enhanced his research and development efforts in cancer prediction.

Conclusion

Harish Srinivasan is a prominent figure in the realm of cancer prediction, with innovative patents that aim to improve patient outcomes. His work continues to influence the field and offers hope for advancements in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…